Neuroblastoma Awareness Week: Dr Katherine Pillman's research to improve diagnosis, treatment
07/02/2025
2-9 February 2025 is Neuroblastoma Awareness Week – a week-long campaign to raise awareness about neuroblastoma, the most common solid tumour found in children.
Dun deal: Australian Government commits $20 million to brain cancer research
06/02/2025
The Kids’ Cancer Project-backed researcher, Professor Matt Dun, has become the beneficiary as part of a $20 million injection from the Australian federal government into childhood brain cancer research.
Blue Sky Services are saying K’day to a better tomorrow for kids with cancer
05/02/2025
On 15 February, The Kids’ Cancer Project seeks to raise funds and awareness for childhood cancer for K’day, coinciding with International Childhood Cancer Day.
New Funding Partnership Backs Innovative Paediatric Brain Cancer Treatment
03/02/2025
The Kids’ Cancer Project is proud to have joined forces with five other leading philanthropic organisations to form the TarGeT Collaborative – a pioneering partnership which has been established to fund critical clinical trials for targeted treatments in children and young adults diagnosed with high-grade gliomas, including Diffuse Intrinsic Pontine Glioma (DIPG).
K'day 2025: How Rachel Edwards plans to change the lives of kids undergoing BMT
13/01/2025
Queensland nurse researcher Rachel Edwards knows first-hand the effects of severe treatments of children’s cancer, because she’s on the ground every day.
Kenny Ip: Utilising neuroscience for drug development
14/10/2024
Dr Kenny Ip, a molecular neuroscientist at the Children’s Cancer Institute, has carved out a career of note in a relatively short timeframe. In an eight-year period, he has released some 20 publications on complex brain circuits in an array of high-tier journals.
A Decade of Funding Leads to a Neuroblastoma Breakthrough
18/07/2024
The Kids’ Cancer Project investment of over $700,000 for access to the drug DFMO (difluoromethylornithine) and Phase One of a clinical trial for children with relapsed high-risk neuroblastoma over a decade ago was our first investment into Professor David Ziegler’s groundbreaking neuroblastoma research in 2014.
The Better Challenge: Funding exercise oncology research
09/07/2024
As we gear up for the Better Challenge, Accredited Exercise Physiologist Dr David Mizrahi reveals the magic of movement in kids’ cancer recovery, and the power of your donations in enabling greater knowledge.
Rare Cancers Awareness Day
26/06/2024
The treatments and drugs used for adults are not directly transferable to children, and there are no obvious behavioural preventions like giving up smoking or staying out of the sun. By definition, all childhood cancers are rare, making up less than one percent of the total number of new cancer diagnoses in Australia each year.
Funding secured for Interfant-21 clinical trial
15/05/2024
Infant Acute Lymphoblastic Leukaemia (ALL) has had a very poor prognosis and survival has not improved significantly over the last two decades, with an event-free survival rate of less than 40%. The intensive chemotherapy treatment currently available necessitates high toxicity often leading to treatment related mortality.
Eliminating the serious side effects of chemotherapy
29/04/2024
For many children, the very same cancer drugs used to save their lives can all too often leave them with very serious and lifelong health problems. Professor Irina Vetter is finding ways to maintain the effectiveness of chemotherapy drugs whilst eliminating their incredibly harmful side effects.
Celebrating a decade of collaborative funding leading to over $10 million committed to ground-breaking research
02/04/2024
Minister for Health and Aged Care, the Hon Mark Butler MP today announced the successful grant recipients to receive funding for innovative cancer research through the 2023 round of the Cancer Australia Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
Displaying results
37
-
48
of
94
Pages